38689-24-6 Usage
Description
(2R)-2-amino-3-(1H-indol-3-yl)propionamide, also known as tryptophanamide, is a compound belonging to the class of amino acids. It is a derivative of the essential amino acid tryptophan, which plays a crucial role in the synthesis of proteins and serves as a precursor to serotonin and melatonin. Tryptophanamide is involved in various biological processes, including the regulation of mood, appetite, and sleep.
Uses
Used in Pharmaceutical Industry:
(2R)-2-amino-3-(1H-indol-3-yl)propionamide is used as a key component in the development of drugs for the treatment of depression, anxiety, and sleep disorders. Its involvement in the regulation of mood, appetite, and sleep makes it a promising candidate for pharmaceutical applications.
Used in Cancer Therapy Research:
(2R)-2-amino-3-(1H-indol-3-yl)propionamide is used as a potential therapeutic agent in cancer therapy. Its role in various biological processes and its ability to interact with specific targets make it a candidate for further research and development in oncology.
Used in Neurodegenerative Disease Treatment:
(2R)-2-amino-3-(1H-indol-3-yl)propionamide is used as a potential treatment for neurodegenerative diseases. Its involvement in physiological processes and its potential to modulate specific pathways make it a candidate for further exploration in the treatment of such conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 38689-24-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,6,8 and 9 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 38689-24:
(7*3)+(6*8)+(5*6)+(4*8)+(3*9)+(2*2)+(1*4)=166
166 % 10 = 6
So 38689-24-6 is a valid CAS Registry Number.
38689-24-6Relevant articles and documents
COMPOUNDS AND METHOD OF USE
-
Paragraph 0997, (2019/09/06)
This present disclosure relates to compounds with ferroptosis inducing activity, a method of treating a subject with cancer with the compounds, and combination treatments with a second therapeutic agent.
Production of L-tryptophan by enantioselective hydrolysis of d,l-tryptophanamide using a newly isolated bacterium
Xu, Jian-Miao,Chen, Ben,Wang, Yuan-Shan,Zheng, Yu-Guo
, p. 1262 - 1270 (2013/07/19)
Bacterial strain ZJB-09211 capable of amidase production has recently been isolated from soil samples. The strain is able to asymmetrically hydrolyze l-tryptophanamide from d,l-tryptophanamide to produce l-tryptophan in high yield and with excellent stereoselectivity (enantiomeric excess > 99.9 %, and enantiomeric ratio > 200). Strain ZJB-09211 has been identified as Flavobacterium aquatile based on the cell morphology analysis, physiological tests, and the 16S rDNA sequence analysis. Optimization of the fermentation medium led to an about six-fold increase in the amidase activity of strain ZJB-09211, which reached 501.5 U L-1. Substrate specifity and stereoselectivity investigations revealed that amidase of F. aquatile possessed a broad substrate spectrum and high enantioselectivity.
